These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1358708)

  • 1. The effect of desogestrel for hormone replacement therapy on the blood lipid profiles of postmenopausal women.
    Tadmor OP; Kleinman Y; Goldstein R; Diamant YZ
    Int J Gynaecol Obstet; 1992 Oct; 39(2):105-10. PubMed ID: 1358708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of two fixed hormonal replacement therapy protocols on blood lipid profile.
    Tadmor OP; Kleinman Y; Reisin A; Livshin Y; Diamant YZ
    Eur J Obstet Gynecol Reprod Biol; 1992 Sep; 46(2-3):109-16. PubMed ID: 1333421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974-2000.
    Godsland IF
    Fertil Steril; 2001 May; 75(5):898-915. PubMed ID: 11334901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a lipid lowering fibrate and hormone replacement therapy on serum lipids and lipoproteins in overweight postmenopausal women with elevated triglycerides.
    Nerbrand C; Nyberg P; Nordström L; Samsioe G
    Maturitas; 2002 May; 42(1):55-62. PubMed ID: 12020980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of continuous combined estrogen and desogestrel hormone replacement therapy on serum lipids and lipoproteins.
    Marsh MS; Crook D; Whitcroft SI; Worthington M; Whitehead MI; Stevenson JC
    Obstet Gynecol; 1994 Jan; 83(1):19-23. PubMed ID: 8272301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of combined oral estrogen/progestogen preparation (Kliogest) on bone mineral density, plasma lipids and postmenopausal symptoms in HRT-naïve Thai women.
    Jirapinyo M; Theppisai U; Manonai J; Suchartwatnachai C; Jorgensen LN
    Acta Obstet Gynecol Scand; 2003 Sep; 82(9):857-66. PubMed ID: 12911449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormone replacement therapy and lipid-lipoprotein concentrations.
    Gökmen O; Yapar Eyi EG
    Eur J Obstet Gynecol Reprod Biol; 1999 Jul; 85(1):31-41. PubMed ID: 10428319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
    Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
    Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
    Godsland IF; Crook D; Simpson R; Proudler T; Felton C; Lees B; Anyaoku V; Devenport M; Wynn V
    N Engl J Med; 1990 Nov; 323(20):1375-81. PubMed ID: 2146499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of hormone replacement therapy on lipoprotein(a) and lipid levels in postmenopausal women. Influence of various progestogens and duration of therapy.
    Kim CJ; Min YK; Ryu WS; Kwak JW; Ryoo UH
    Arch Intern Med; 1996 Aug 12-26; 156(15):1693-700. PubMed ID: 8694668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effects of oral and transdermal hormone replacement therapies on serum lipid and lipoprotein concentrations.
    Whitcroft SI; Crook D; Marsh MS; Ellerington MC; Whitehead MI; Stevenson JC
    Obstet Gynecol; 1994 Aug; 84(2):222-6. PubMed ID: 8041534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of dydrogesterone and norethisterone, in combination with oestradiol, on lipoproteins and inflammatory markers in postmenopausal women.
    Kwok S; Charlton-Menys V; Pemberton P; McElduff P; Durrington PN
    Maturitas; 2006 Mar; 53(4):439-46. PubMed ID: 16139447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of raloxifene and continuous combined hormone replacement therapy on biochemical markers of cardiovascular risk: results from the Euralox 1 study.
    Nickelsen T; Creatsas G; Rechberger T; Depypere H; Erenus M; Quail D; Arndt T; Bonnar J;
    Climacteric; 2001 Dec; 4(4):320-31. PubMed ID: 11770189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral contraceptive tablets containing 20 and 30 micrograms of ethinyl estradiol with 150 micrograms desogestrel. Their influence on lipids, lipoproteins, sex hormone binding globulin and testosterone.
    Akerlund M; Almström E; Högstedt S; Nabrink M
    Acta Obstet Gynecol Scand; 1994 Feb; 73(2):136-43. PubMed ID: 8116352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized trial of effects of estradiol in combination with either norethisterone acetate or trimegestone on lipids and lipoproteins in postmenopausal women.
    Al-Azzawi F; Wahab M; Sami S; Proudler AJ; Thompson J; Stevenson J
    Climacteric; 2004 Sep; 7(3):292-300. PubMed ID: 15669554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of two dosages of a continuous combined hormone replacement regimen.
    Loh FH; Chen LH; Yu SL; Jorgensen LN
    Maturitas; 2002 Feb; 41(2):123-31. PubMed ID: 11836043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined hormone replacement therapy with oestradiol and norethisterone acetate: effects in hyperlipidaemia.
    Tonstad S
    Br J Obstet Gynaecol; 1996 May; 103 Suppl 13():45-8. PubMed ID: 8624342
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of continuous combined conjugated estrogen/medroxyprogesterone acetate and 17beta-estadiol/norethisterone acetate on lipids and lipoproteins.
    Odmark IS; Bäckström T; Haeger M; Jonsson B; Bixo M
    Maturitas; 2004 Jun; 48(2):137-46. PubMed ID: 15172088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum lipids, lipoproteins, and apolipoproteins during postmenopausal estrogen replacement therapy combined with either 19-nortestosterone derivatives or 17-hydroxyprogesterone derivatives.
    Haarbo J; Hassager C; Jensen SB; Riis BJ; Christiansen C
    Am J Med; 1991 May; 90(5):584-9. PubMed ID: 1827568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
    Teichmann A
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.